On the morning of the 7th, medical-sector stocks such as medical devices and digital healthcare showed mixed movements across the board, with some stocks posting sharp gains. L&C Bio jumped more than 20%, while Rokit Healthcare, PNS Robotics, and Cairs also showed relative strength.

■ L&C Bio Soars 23.35%... Rises to 5,400 Won Intraday

As of this morning, L&C Bio is trading at 5,230 won, up 23.35% from the previous session. It opened at 4,305 won and surged as high as 5,400 won intraday, with volume exceeding 550,000 shares.

Rokit Healthcare is trading at 26,625 won, up 4.82%, after rising as high as 27,300 won intraday. Cairs is up 3.75% at 22,150 won, with an intraday high of 22,450 won.

■ Surgical Robot and Medical Device Stocks Also Rise

Medical robot-related stocks are also climbing. PNS Robotics is trading at 5,220 won, up 4.19%. Curexo is up 1.85% at 8,280 won, and Goyang has risen 1.43% to 28,300 won.

Among medical device stocks, Hans Biomed (3.16%), Vieworks (3.04%), and Cgimeditech (2.83%) are advancing. They are followed by Rayence up 2.40%, C.U. Medical up 1.89%, Osteonic up 1.79%, Dentium up 1.60%, and InBody up 1.47%.

■ Medical AI and Diagnostics Stocks Mixed

Meanwhile, medical AI-related stocks are somewhat mixed. Vuno is up 0.38%, but Lunit (0.56%), Deepnoid (0.79%), and Neurphet (1.23%) are declining. JLK is also down 0.53%.

Diagnostics stocks also show wide disparities. Nanobiotec and Boditech Med are up 1.32% and 1.02%, respectively, while Sugentech and Precision Bio are weakening.

■ Diverging Trends Within the Theme... Individual Stock Review Needed

Medical-sector stocks span a wide range of business areas, from medical devices to medical AI, diagnostics, surgical robots, dental and orthopedic equipment, and aesthetic medicine, so share price movements can vary greatly even within the same medical theme.

In particular, rather than the entire medical sector moving in unison today, strong buying is concentrated in select individual stocks, led by L&C Bio. Therefore, it is necessary to examine each company's upward catalysts, volume changes, and actual business areas separately.

[※ This article was written to provide information on the domestic stock market and related stocks, and does not recommend buying or selling any specific stock or guarantee investment returns. Stock prices can change rapidly depending on market conditions, and investment decisions and the responsibility for them rest with the investor. This article was written with AI assistance.]